Christopher A. Maher

22.0k total citations · 4 hit papers
87 papers, 7.5k citations indexed

About

Christopher A. Maher is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christopher A. Maher has authored 87 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 49 papers in Cancer Research and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christopher A. Maher's work include Cancer-related molecular mechanisms research (26 papers), RNA modifications and cancer (21 papers) and Cancer Genomics and Diagnostics (17 papers). Christopher A. Maher is often cited by papers focused on Cancer-related molecular mechanisms research (26 papers), RNA modifications and cancer (21 papers) and Cancer Genomics and Diagnostics (17 papers). Christopher A. Maher collaborates with scholars based in United States, Canada and Switzerland. Christopher A. Maher's co-authors include Arul M. Chinnaiyan, Nallasivam Palanisamy, Xuhong Cao, Ha X. Dang, Xiaojun Jing, Doreen Ware, Arul M. Chinnaiyan, Chandan Kumar‐Sinha, Bo Han and Matthew K. Iyer and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Christopher A. Maher

85 papers receiving 7.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer

2008 833 citations Sooryanarayana Varambally, Qi Cao et al. Science profile →
Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression

2011 815 citations Qi Cao, J. Chad Brenner et al. profile →
Transcriptome sequencing to detect gene fusions in cancer

2009 631 citations Christopher A. Maher, Chandan Kumar‐Sinha et al. profile →
Long noncoding RNAs in cancer metastasis

2021 441 citations Siyuan Liu, Ha X. Dang et al. Nature reviews. Cancer profile →

Peers

Countries citing papers authored by Christopher A. Maher

Since Specialization

Citations

This map shows the geographic impact of Christopher A. Maher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher A. Maher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher A. Maher more than expected).

Fields of papers citing papers by Christopher A. Maher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher A. Maher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher A. Maher. The network helps show where Christopher A. Maher may publish in the future.

Co-authorship network of co-authors of Christopher A. Maher

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher A. Maher. A scholar is included among the top collaborators of Christopher A. Maher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher A. Maher. Christopher A. Maher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	BCAR4 Expression as a Predictive Biomarker for Endocrine Therapy Resistance in Breast Cancer 2024 ·Clinical Breast Cancer ·(unknown), (unknown), Emily Coonrod, Katherine N. Weilbaecher, Christopher A. Maher, Nicole M. White	2
2	Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression 2024 ·Nature Cell Biology ·Meng Zhang, Martin Sjöström, Xiekui Cui, (unknown), Kyle Kai‐How Farh, Raunak Shrestha, Arian Lundberg, Ha X. Dang, (unknown), Phillip G. Febbo, Rahul Aggarwal, Joshi J. Alumkal, (unknown), (unknown), Felix Y. Feng, (unknown), (unknown), David A. Quigley, (unknown), Christopher A. Maher, (unknown)	2
3	Single cell-transcriptomic analysis informs the lncRNA landscape in metastatic castration resistant prostate cancer 2024 ·npj Genomic Medicine ·(unknown), Ha X. Dang, Meng Zhang, David A. Quigley, Felix Y. Feng, Christopher A. Maher	2
4	CrypticProteinDB: an integrated database of proteome and immunopeptidome derived non-canonical cancer proteins 2023 ·NAR Cancer ·(unknown), Christopher A. Maher	4
5	Characterization of cell-type specific circular RNAs associated with colorectal cancer metastasis 2023 ·NAR Cancer ·Sidi Zhao, Amy Ly, Jacqueline L. Mudd, Emily B. Rozycki, (unknown), Emily Coonrod, (unknown), Jingqin Luo, Ha X. Dang, Ryan C. Fields, Christopher A. Maher	3
6	Single-cell transcriptomics reveals long noncoding RNAs associated with tumor biology and the microenvironment in pancreatic cancer 2023 ·NAR Cancer ·Ha X. Dang, (unknown), Reyka G. Jayasinghe, Sidi Zhao, Emily Coonrod, Jacqueline L. Mudd, S. Peter Goedegebuure, Ryan C. Fields, Li Ding, Christopher A. Maher	1
7	INTEGRATE-Circ and INTEGRATE-Vis: unbiased detection and visualization of fusion-derived circular RNA 2023 ·Bioinformatics ·(unknown), (unknown), Amy Ly, Christopher A. Maher	2
8	Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survival 2023 ·Communications Biology ·(unknown), Mary M. Mullen, Nicholas C. Spies, Tiandao Li, Matthew Inkman, Jin Zhang, Fernanda Martins Rodrigues, Ian S. Hagemann, Carolyn K. McCourt, Premal H. Thaker, Andrea R. Hagemann, Matthew A. Powell, David G. Mutch, Dineo Khabele, Gregory D. Longmore, Elaine R. Mardis, Christopher A. Maher, Christopher A. Miller, Katherine C. Fuh	18
9	PACT: a pipeline for analysis of circulating tumor DNA 2023 ·Bioinformatics ·(unknown), Ha X. Dang, Pradeep S. Chauhan, Wenjia Feng, (unknown), Peter K. Harris, Russell K. Pachynski, Aadel A. Chaudhuri, Christopher A. Maher	1
10	Pan-Cancer Analysis Reveals Recurrent BCAR4 Gene Fusions across Solid Tumors 2022 ·Molecular Cancer Research ·Andrew Nickless, Jin Zhang, (unknown), (unknown), Matthew Inkman, Emily Coonrod, (unknown), Emily B. Rozycki, Christopher A. Maher, Nicole M. White	6
11	LINC00355 regulates p27KIP expression by binding to MENIN to induce proliferation in late-stage relapse breast cancer 2022 ·npj Breast Cancer ·Abdallah M. Eteleeb, (unknown), (unknown), Cynthia Y. Tang, Emily B. Rozycki, Alexander L. Miller, Jonathan T. Lei, Reyka G. Jayasinghe, Ha X. Dang, Nicole M. White, Jorge S. Reis‐Filho, Elaine R. Mardis, Matthew J. Ellis, Li Ding, Jessica Silva-Fisher, Christopher A. Maher	7
12	Phase 1 study combining alisertib with nab-paclitaxel in patients with advanced solid malignancies 2021 ·European Journal of Cancer ·Kian‐Huat Lim, Mateusz Opyrchal, (unknown), (unknown), Ningying Wu, Feng Gao, (unknown), A. Craig Lockhart, Saiama N. Waqar, Ramaswamy Govindan, Daniel Morgensztern, Joel Picus, Benjamin Tan, Maria Q. Baggstrom, Christopher A. Maher, Andrea Wang‐Gillam	9
13	Long noncoding RNAs in cancer metastasis breakdown → 2021 ·Nature reviews. Cancer ·Siyuan Liu, Ha X. Dang, Daniel A. Lim, Felix Y. Feng, Christopher A. Maher	441
14	Diverse AR Gene Rearrangements Mediate Resistance to Androgen Receptor Inhibitors in Metastatic Prostate Cancer 2020 ·Clinical Cancer Research ·Yingming Li, Rendong Yang, Christine Henzler, Yeung Ho, Courtney N. Passow, Benjamin Auch, Suzanne Carreira, Daniel Nava Rodrigues, Cláudia Bertan, Tae Hyun Hwang, David A. Quigley, Ha X. Dang, Colm Morrissey, Michael Fraser, Stephen R. Plymate, Christopher A. Maher, Felix Y. Feng, Johann S. de Bono, Scott M. Dehm	62
15	Pan-cancer proteogenomic analysis reveals long and circular noncoding RNAs encoding peptides 2020 ·NAR Cancer ·(unknown), Emily Coonrod, Sidi Zhao, Ha X. Dang, Christopher A. Maher	16
16	Heparin-based hydrogel scaffolding alters the transcriptomic profile and increases the chemoresistance of MDA-MB-231 triple-negative breast cancer cells 2020 ·Biomaterials Science ·(unknown), Ha X. Dang, (unknown), (unknown), Christopher B. Lawrence, Christopher A. Maher, Caroline N. Jones	16
17	SV-HotSpot: detection and visualization of hotspots targeted by structural variants associated with gene expression 2020 ·Scientific Reports ·Abdallah M. Eteleeb, David A. Quigley, Shuang G. Zhao, Duy Pham, Rendong Yang, Scott M. Dehm, Jingqin Luo, Felix Y. Feng, Ha X. Dang, Christopher A. Maher	2
18	Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types 2019 ·Clinical Cancer Research ·William S. Chen, Mohammed Alshalalfa, Shuang G. Zhao, Yang Liu, Brandon A. Mahal, David A. Quigley, Ting Wei, Elai Davicioni, Timothy R. Rebbeck, Philip W. Kantoff, Christopher A. Maher, Karen E. Knudsen, Eric J. Small, Paul L. Nguyen, Felix Y. Feng	34
19	Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer breakdown → 2008 ·Science ·Sooryanarayana Varambally, Qi Cao, Ram S. Mani, Sunita Shankar, Xiaosong Wang, Bushra Ateeq, Bharathi Laxman, Xuhong Cao, Xiaojun Jing, Kalpana Ramnarayanan, J. Chad Brenner, Jindan Yu, Jung H. Kim, Bo Han, Patrick Tan, Chandan Kumar‐Sinha, Robert J. Lonigro, Nallasivam Palanisamy, Christopher A. Maher, Arul M. Chinnaiyan	833
20	Multi-resident AFS: an adventure in mass storage 1995 ·USENIX Annual Technical Conference ·(unknown), (unknown), (unknown), Christopher A. Maher, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact